K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
CALGB 90601 (Alliance): Randomized, double-blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma.
Jonathan E. Rosenberg,Karla V. Ballman,Susan Halabi,Colleen Watt,Olwen Hahn,Preston D. Steen,Robert Dreicer,Thomas W. Flaig,Walter M. Stadler,Christopher Sweeney,Amir Mortazavi,Michael J. Morris +11 more
TL;DR: This data indicates that angiogenesis plays a role in UC growth and cisplatin treatment with gemcitabine-C is a standard therapy for metastatic urothelial carcinoma.
Journal ArticleDOI
Elevated expressions of osteopontin and tenascin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves
Ramanath Majumdar,Dylan V. Miller,Karla V. Ballman,Gopinathan Unnikrishnan,Stephen H. McKellar,Gobinda Sarkar,Raghavakaimal Sreekumar,Mark E. Bolander,Thoralf M. Sundt +8 more
TL;DR: The objective of this investigation was to compare the patterns of gene expression in aortas between TAV and BAV patients with the aim of identifying markers for AscAAs and identified two novel potential markers, OPN and TNC, that are strongly associated with TAV aneurysms.
Journal ArticleDOI
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Michael Glikson,Igor Lipchenca,Igor Lipchenca,Sami Viskin,Karla V. Ballman,M R N Jane Trusty,Osnat T. Gurevitz,David M. Luria,Michael Eldar,Stephen C. Hammill,Paul A. Friedman +10 more
TL;DR: The goal of this study was to estimate future risk of unstable ventricular arrhythmias in patients who received ICDs for stable VT.
Journal ArticleDOI
Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location
TL;DR: In this study population of early-onset atherosclerotic PAD, men and women were equally represented and the disease involved predominantly the aortoiliac location.
Journal ArticleDOI
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan Shepherd,Karla V. Ballman,Mei Yin C. Polley,J. Campbell,Cheng Fan,Sara R. Selitsky,Aranzazu Fernandez-Martinez,Joel S. Parker,Katherine A. Hoadley,Zhiyuan Hu,Yan Li,Matthew G. Soloway,Patricia A. Spears,Baljit Singh,Sara M. Tolaney,George Somlo,Elisa Port,Cynthia X. Ma,Charles S. Kuzma,Eleftherios P. Mamounas,Mehra Golshan,Jennifer R. Bellon,Deborah Collyar,Olwen Hahn,Clifford A. Hudis,Eric P. Winer,Ann H. Partridge,Terry Hyslop,Lisa A. Carey,Charles M. Perou,William M. Sikov +30 more
TL;DR: Despite higher pCR rates, neither carboplatin nor bevacizumab appeared to improve LTOs although the study was not powered to assess these secondary end points.